The authors demonstrated that IL-6 derived from fibroblasts in a primary pancreatic tumor binds to its receptor on hepatocytes, the main cell type in the liver, and drives the expression and activation of STAT3. The gene discussed is IL6; the disease is pancreatic neoplasm.